Thursday, June 21, 2018 05:02 AM

ISRAEL'S UROGEN TO START MID-STAGE BLADDER CANCER TRIAL

RAANANA, Israel (Reuters) - Israel's UroGen Pharma plans to begin a mid-stage trial of its treatment for bladder cancer patients in August, after positive interim results last month from an advanced trial of a treatment for upper urinary tract cancer.

News source: Reuters

See also: The Robotic Urologist